1 / 20

Embolia Polmonare Acuta: Terapia medica, interventistica e chirurgica Loris Roncon Rovigo

Firenze 5 Novenbre 2010. Embolia Polmonare Acuta: Terapia medica, interventistica e chirurgica Loris Roncon Rovigo. Heart 2010; 96:1418-1424. PE Treatmen t :Begin with anticolagulatio;Consider advanced therapy for high risk patients Goldhaber.

leyna
Télécharger la présentation

Embolia Polmonare Acuta: Terapia medica, interventistica e chirurgica Loris Roncon Rovigo

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Firenze 5 Novenbre 2010 Embolia Polmonare Acuta: Terapia medica, interventistica e chirurgica Loris Roncon Rovigo

  2. Heart 2010; 96:1418-1424

  3. PE Treatment :Begin with anticolagulatio;Consider advanced therapy for high risk patients Goldhaber

  4. Kostantinides S: N Engl J Med 2008;359:2804-13

  5. EMBOLIA POLMONARE A RISCHIO INTERMEDIO: TROMBOLISI

  6. EMBOLIA POLMONARE A RISCHIO INTERMEDIO: TROMBOLISI

  7. EMBOLIA POLMONARE A RISCHIO INTERMEDIO: TROMBOLISI

  8. EMBOLIA POLMONARE A BASSO RISCHIO

  9. EMBOLIA POLMONARE AD ALTO RISCHIO • Disponibilità sala operatoria • Accesso • Tempi trasp Mortalità 20-50% -età -durata dei sintomi - rianimazione pre int. -n°episodi di E.P. • Controindicazioni assolute alla trombolisi • Inefficacia della trombolisi • Associata al trombolitico?

  10. Terapia Eparinica PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%) TAO in corso 32 (3.2%) Profilassi con eparina 149 (14.6%)

  11. PZ1024 137 (13.4%) 537 (52.4%) 193 338 (33.4%)

  12. Terapia Eparinica PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%)

  13. Terapia Eparinica PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%) • Pz con neoplasia 230 (22.5 %) • ingresso per EP 178 (17.5%) • Diagnosi • durante ricovero per EP 52(5%)

  14. Trombolisi PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%) PZ trattati con trombolisi tot. 126

  15. Trombolisi PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%)

  16. Terapia complicanze Complicanze emorragiche • Emorragie intracraniche 0.6% (6 pz) • trombolisi 2.4 % (3/126pz) • eparina (enoxaparina) 0.4% (3/981 pz) • trombolisi 2.4 % (3/126pz) • tutti con E.P. rischio intermedio • fascia di età : 1 - 61-70 a. • 2 - 81-90 a. • mortali 2 PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%)

  17. Terapia • Embolia polmonare: altre terapie • Chirugica 0.1% (1) • Trombectomia percutanea 1.2% (12) • Alto rischio 41.6% (5) • Rischio Intermedio 58.4% (7) PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%)

  18. Terapia • Embolia polmonare: altre terapie • Filtro cavale 4.2% (43 pz) • filtro cavale + trombo flottante 2 pz PZ 1024 137 (13.4%) 537 (52.4%) 338 (33.4%)

  19. Terapia

More Related